257 related articles for article (PubMed ID: 11121627)
1. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.
Fisher J; Scott C; Stevens R; Marconi B; Champion L; Freedman GM; Asrari F; Pilepich MV; Gagnon JD; Wong G
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1307-10. PubMed ID: 11121627
[TBL] [Abstract][Full Text] [Related]
2. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
[TBL] [Abstract][Full Text] [Related]
3. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
4. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity.
Williams MS; Burk M; Loprinzi CL; Hill M; Schomberg PJ; Nearhood K; O'Fallon JR; Laurie JA; Shanahan TG; Moore RL; Urias RE; Kuske RR; Engel RE; Eggleston WD
Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):345-9. PubMed ID: 8892458
[TBL] [Abstract][Full Text] [Related]
5. Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.
Fenig E; Brenner B; Katz A; Sulkes J; Lapidot M; Schachter J; Malik H; Sulkes A; Gutman H
Oncol Rep; 2001; 8(2):305-9. PubMed ID: 11182045
[TBL] [Abstract][Full Text] [Related]
6. The effect of aloe vera gel/mild soap versus mild soap alone in preventing skin reactions in patients undergoing radiation therapy.
Olsen DL; Raub W; Bradley C; Johnson M; Macias JL; Love V; Markoe A
Oncol Nurs Forum; 2001 Apr; 28(3):543-7. PubMed ID: 11338761
[TBL] [Abstract][Full Text] [Related]
7. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal trends in skin-related and global quality of life among women with breast radiodermatitis: A pilot study.
Beamer LC; Grant M
Eur J Oncol Nurs; 2018 Apr; 33():22-27. PubMed ID: 29551173
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
10. Three-Arm Randomized Phase III Trial: Quality Aloe and Placebo Cream Versus Powder as Skin Treatment During Breast Cancer Radiation Therapy.
Hoopfer D; Holloway C; Gabos Z; Alidrisi M; Chafe S; Krause B; Lees A; Mehta N; Tankel K; Strickland F; Hanson J; King C; Ghosh S; Severin D
Clin Breast Cancer; 2015 Jun; 15(3):181-90.e1-4. PubMed ID: 25619686
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness, safety, and economic evaluation of topical application of a herbal ointment, Jaungo, for radiation dermatitis after breast conserving surgery in patients with breast cancer (GREEN study): Study protocol for a randomized controlled trial.
Shin S; Jang BH; Suh HS; Park SH; Lee JW; Yoon SW; Kong M; Lim YJ; Hwang DS
Medicine (Baltimore); 2019 Apr; 98(15):e15174. PubMed ID: 30985703
[TBL] [Abstract][Full Text] [Related]
12. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
13. A Phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue.
Heggie S; Bryant GP; Tripcony L; Keller J; Rose P; Glendenning M; Heath J
Cancer Nurs; 2002 Dec; 25(6):442-51. PubMed ID: 12464836
[TBL] [Abstract][Full Text] [Related]
14. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
15. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
16. Optimal Topical Agent for Radiation Dermatitis During Breast Radiotherapy: A Pilot Study.
Fenton-Kerimian M; Cartwright F; Peat E; Florentino R; Maisonet O; Budin W; Rolnitzky L; Formenti S
Clin J Oncol Nurs; 2015 Aug; 19(4):451-5. PubMed ID: 26207710
[TBL] [Abstract][Full Text] [Related]
17. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
18. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
19. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
Pommier P; Gomez F; Sunyach MP; D'Hombres A; Carrie C; Montbarbon X
J Clin Oncol; 2004 Apr; 22(8):1447-53. PubMed ID: 15084618
[TBL] [Abstract][Full Text] [Related]
20. A prospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy.
Gosselin TK; Schneider SM; Plambeck MA; Rowe K
Oncol Nurs Forum; 2010 Sep; 37(5):619-26. PubMed ID: 20797953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]